What is Tylosin Base Market?
Tylosin Base is used in a veterinary medicine to treat felines, canines and livestock. It is a bacteriostatic feed additive and found as a fermentation product Streptomyces fradiae. Furthermore it is used in cattle, pigs and poultry for the treatment of infections caused by organisms.
Highlights from Tylosin Base Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | Eli Lilly (United States), Huvepharma (United States), Shandong Lukang (China), Hengtong Guanghua (China) and Ningxia Tairui (China) |
Research Analyst at AMA predicts that United States Vendors will contribute to the maximum growth of Global Tylosin Base market throughout the forecasted period.
Eli Lilly (United States), Huvepharma (United States), Shandong Lukang (China), Hengtong Guanghua (China) and Ningxia Tairui (China) are some of the key players profiled in the study. Tylosin Base Market Segmentation:
Scope | Sub-Segments |
---|
Application / End User | Feed Additives and Poultry Medicine |
Form | Crystal,Liquid |
Livestock species | Beef cattle,Dairy Cattle,Swine |
On the basis of geography, the market of Tylosin Base has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Technological Innovations are Being Done and Investments in Research and Developments
Market Growth Drivers:
Having Medicinal Properties Used to Treat Cattle, Pigs and Poultry and Increasing Demand as a Feed Additive
Challenges:
Lack of Awareness About the Tylosin Base and Limited Availability of Players will Hamper the Growth
Restraints:
Government Regulations Available for the Chemicals Used and High Costs Associated with the Research and Development
Opportunities:
Rising Diseases in Animals across the Globe and Increasing Demand in Developing Countries
Key Target Audience
Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations
Market Leaders & Development Strategies
In 2018, Huvepharma announced that it had acquired the Animal Health division of Neovia from InVivo Group which will help in expanding a livestock animal health products